First treatment for babies with ultra-rare spectrum of autoinflammatory diseases now available in UK

Anakinra (Kineret®), an interleukin-1 (IL-1) inhibitor, is now available in the UK for treatment of CAPS in children and adults.
Pain / Anesthetics News From Medical News Today

Share:

Related Content